How To Deal With ADHD

Treatments And Drugs Of Did News

OSU study: Leukemia drug shows promise - Columbus Dispatch

OSU study: Leukemia drug shows promise Columbus Dispatch It's also important to figure out the long-term effects of the pill, how it might work with other treatments and how cost-effective it might be, they wrote. Ibrutinib's maker, Pharmacyclics of California, has not said what it plans to charge for the ... OSU: Pill Showing Success In Treating Form Of LeukemiaNBC4i.com all 4 news articles »

Maine House OKs extending drug treatment coverage - WCSH-TV

Maine House OKs extending drug treatment coverage WCSH-TV AUGUSTA, Maine (AP) - The Maine state House has approved a bill to extend MaineCare coverage for certain drug addiction treatments to more than two years. The House gave final approval to the bill on Wednesday. It allows for the continuation of ... and more »

IMS Healthcare says appropriate use of medicines can save over $200 billion in ... - pharmabiz.com

Newsday

IMS Healthcare says appropriate use of medicines can save over $200 billion in ... pharmabiz.com The report – Avoidable Costs in US Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly – examines six areas that contribute to unnecessary costs: medication non-adherence, delayed evidence-based treatment practice, misuse ... Study: Wiser medication use could cut health costsArizona Daily Star Study: Wiser medication use may cut health care costsNewsday all 81 news articles »

People prefer going for ayurvedic treatment - Times of India

People prefer going for ayurvedic treatment Times of India Be it a common disease like fever, cough and cold, constipation or diarrhoea, arthritis and urine problem, the ayurvedic drugs are in great demand with patients approaching AYUSH doctors for the treatment. In fact, even women patients with pregnancy ...

Zalicus Publishes Data on Selective Estrogen Receptor Modulators for the ... - PharmiWeb.com (press release)

Zalicus Publishes Data on Selective Estrogen Receptor Modulators for the ... PharmiWeb.com (press release) In the paper entitled ‚ÄúFDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection‚Äù the scientists including drug developers from Zalicus and collaborators from the U.S. Army Medical Research Institute of Infectious Diseases ... and more »